drugset / Trial / NCT02865421

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

NCT02865421

Phase 2 Completed 22 enrolled King Edward Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, characterized by progressive patterned loss of hair from the scalp. The current study has been designed for restoration of hair in AGA by using a combination of stromal vascular fraction (derived from the adipose tissue) and human platelet rich plasma.

Timeline

Start
2017-06-10
Primary completion
2017-08-12
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified
Subject Rexlemestrocel-L Cell therapy

Indications